LYTIR

Company · LARK

Landmark Bancorp Inc.

Name as listed on its exchange; filed with the SEC as LANDMARK BANCORP INC.

Nasdaq's symbol directory lists LARK on Nasdaq as “Landmark Bancorp Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($32K); insiders sold on 9 occasions ($187K); 5 planned-sale notices; 1 filing by holders of 5% or more; 5 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $32K in total; Insider sales: $187K in total.Aug: Insider purchases $32KSep: Insider sales $21KOct: Insider sales $24KNov: Insider sales $142KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $32KInsider sales below: $187K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. ALEXANDER PATRICK L sold on 5 days latest Nov 5, 2026 sold $149K
  2. LEWIS JIM sold on 4 days 3 of them under a 10b5-1 plan latest Oct 30, 2026 sold $38K
  3. Mark J. Kohlrus bought on 2 days latest Aug 7, 2026 bought $32K
Every trade (11)
  1. SELLALEXANDER PATRICK L sold Nov 5, 2026 350 shares filing $11K
  2. SELLALEXANDER PATRICK L sold Nov 4, 2026 3,018 shares filing $98K
  3. SELLALEXANDER PATRICK L sold Nov 3, 2026 2 shares filing $65
  4. SELLALEXANDER PATRICK L sold Nov 2, 2026 1,000 shares filing $32K
  5. SELLLEWIS JIM sold Oct 30, 2026 550 shares 10b5-1 plan (scheduled) filing $18K
  6. SELLLEWIS JIM sold Oct 29, 2026 26 shares 10b5-1 plan (scheduled) filing $844
  7. SELLLEWIS JIM sold Oct 27, 2026 183 shares 10b5-1 plan (scheduled) filing $6K
  8. SELLLEWIS JIM sold Sep 15, 2026 400 shares filing $13K
  9. SELLALEXANDER PATRICK L sold Sep 14, 2026 226 shares filing $7K
  10. BUYMark J. Kohlrus bought Aug 7, 2026 799 shares filing $25K
  11. BUYMark J. Kohlrus bought Aug 6, 2026 201 shares filing $6K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. ALEXANDER PATRICK L filed Nov 5, 2026 Director 350 shares planned sale date 11/05/2026 filing $14K
  2. ALEXANDER PATRICK L filed Nov 4, 2026 Director 2,020 shares planned sale date 11/04/2026 filing $66K
  3. ALEXANDER PATRICK L filed Nov 3, 2026 Director 1,000 shares planned sale date 11/03/2026 filing $32K
  4. ALEXANDER PATRICK L filed Nov 2, 2026 Director 1,000 shares planned sale date 11/02/2026 filing $32K
  5. ALEXANDER PATRICK L filed Sep 14, 2026 Director 226 shares planned sale date 09/14/2026 filing $7K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. KORNITZER CAPITAL MANAGEMENT INC /KS filed Oct 5, 2026 Schedule 13G/A passive 385,130 shares filing 6.3%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 5, 2026
  2. Results of operations and financial condition filing Oct 28, 2026
  3. Regulation FD disclosure filing Oct 26, 2026
  4. Departure or appointment of directors or officers filing Oct 26, 2026
  5. Regulation FD disclosure filing Sep 24, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.